Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study
Latest Information Update: 27 Mar 2024
At a glance
- Drugs Cellgram-CKD (Primary)
- Indications Renal failure
- Focus Adverse reactions
- Sponsors Pharmicell
- 21 Mar 2024 Planned End Date changed from 1 Apr 2027 to 1 Mar 2027.
- 21 Mar 2024 Planned primary completion date changed from 1 Dec 2022 to 1 Mar 2027.
- 21 Mar 2024 Status changed from not yet recruiting to active, no longer recruiting.